News Focus
News Focus
icon url

exwannabe

05/22/23 12:12 PM

#595129 RE: sukus #595126

Did shorts know the significance of this? I guess they are too busy shorting nowadays. They shorted a lot of companies lately.


I would think most shorts know that Yervoy was first approved on a Phase 1.

Knowing why some drugs are approved on early trial data is important. Just like knowing why other data might not be worthy of an approval.